Immediate Impact
6 from Science/Nature 60 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
Nanomedicine in cancer therapy
2023 Standout
Works of Kathryn Lees being referenced
A randomized, double blind, biomarker selected, phase II clinical trial of maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma (mUC): Final analysis of the ATLANTIS rucaparib arm.
2022
Active surveillance in prostate cancer
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Kathryn Lees | 31 | 13 | 7 | 101 | 56 | 7 | 180 | |
| CG Knight | 9 | 3 | 6 | 117 | 77 | 6 | 279 | |
| Sargun A. Tont | 21 | 16 | 12 | 42 | 79 | 11 | 243 | |
| Foreman | 8 | 17 | 1 | 28 | 20 | 11 | 265 | |
| Sebastian Sonntag | 6 | 3 | 83 | 75 | 16 | 168 | ||
| Santiago Salazar | 28 | 37 | 2 | 41 | 13 | 14 | 299 | |
| Weizhen Xu | 28 | 4 | 1 | 109 | 5 | 20 | 267 | |
| Clare Evans | 6 | 16 | 46 | 22 | 14 | 129 | ||
| Priya Velusamy | 3 | 14 | 45 | 19 | 7 | 244 | ||
| Margaret E. Fransen | 21 | 2 | 16 | 32 | 11 | 190 | ||
| Óscar Moreno | 2 | 6 | 1 | 66 | 80 | 12 | 263 |
All Works
Loading papers...